NobelPepLab
Home Peptide Catalogue Quality & COAs Shipping & Delivery Resources Sourcing & Verification Guide Handling & Storage Copper Peptides & GHK-Cu Reconstitution Calculator About FAQ Support Message Us on WhatsApp

All products are for laboratory research purposes only. Not for human consumption.

Research blend: CJC-1295 without DAC and ipamorelin co-lyophilised in one vial

CJC-1295 + Ipamorelin

CJC-1295 + Ipamorelin is a two-peptide research preparation containing CJC-1295 without DAC, also sold as modified GRF 1-29, and ipamorelin, co-lyophilised in a single vial at 5 mg of each. The two act on different receptors: CJC-1295 at the growth-hormone-releasing hormone receptor, ipamorelin at the ghrelin receptor GHS-R1a. Supplied as a lyophilised powder in sealed vials, boxed in tens, for laboratory research use only. Unlike most blends sold in this market, the principle behind pairing these two classes has been tested in humans - though not with these two specific molecules, and not at this ratio.

From $11.93 per vial · £9.42

$119.28 (£94.23) per box of 10 vials · CJC-1295 5 mg + Ipamorelin 5 mg

Select size

$119.28 £94.23 per box of 10 vials
$11.93 per vial · £9.42

Boxes

  • Sold in boxes of 10 vials. No minimum order and no trade account.
  • Dispatched in 1–2 working days, tracked to the UK, USA, EU and worldwide.
  • Batch-specific Certificate of Analysis from Janoshik or Freedom Diagnostic in every box.
  • Photographed before it ships, so you see the exact order that leaves us.
Vial of CJC-1295 + Ipamorelin research peptide, supplied in boxes of 10

Overview

What is CJC-1295 + Ipamorelin?

CJC-1295 + Ipamorelin is a two-peptide research preparation containing CJC-1295 without DAC, also sold as modified GRF 1-29, and ipamorelin, co-lyophilised in a single vial at 5 mg of each. The two act on different receptors: CJC-1295 at the growth-hormone-releasing hormone receptor, ipamorelin at the ghrelin receptor GHS-R1a. Supplied as a lyophilised powder in sealed vials, boxed in tens, for laboratory research use only. Unlike most blends sold in this market, the principle behind pairing these two classes has been tested in humans - though not with these two specific molecules, and not at this ratio.

Laboratory research use onlyNobelPepLab supplies CJC-1295 + Ipamorelin strictly for in vitro and laboratory research. We do not provide dosing guidance, do not make health claims, and do not supply products for human or veterinary use.

CJC-1295 + Ipamorelin at a glance

CompoundCJC-1295 + Ipamorelin
Also known asCJC1295 Ipamorelin, CJC-1295 Ipamorelin blend, CJC 1295 ipamorelin, Mod GRF 1-29 with ipamorelin, CJC-1295/Ipamorelin stack
ClassificationResearch blend: CJC-1295 without DAC and ipamorelin co-lyophilised in one vial
Purity99%+ by HPLC
Physical formLyophilised powder
Available strengthsCJC-1295 5 mg + Ipamorelin 5 mg
Box quantity10 vials
Price from$11.93 per vial ($119.28 per box)
Research statusCJC-1295 and ipamorelin each have their own published literature, and unlike most blends in this market the principle behind pairing them has been tested: giving a GHRH analogue together with a growth-hormone-releasing peptide produces a larger growth hormone response in humans than either class produces alone. What has not been tested is this specific pairing at this specific ratio. Neither compound is approved for human use in any country, and both fall under WADA category S2.
DocumentationBatch-specific COA (Janoshik or Freedom Diagnostic)

These are catalogue target specifications, not batch results. The 99%+ purity figure is the specification we buy to. The authoritative figures for any particular box are the ones printed on that box’s Certificate of Analysis, which is lot-specific.

We make no “third-party verified” claim for a batch unless the matching report is supplied with it. Ask for the current COA for the lot in stock before you order — we will send it.

Pricing

How much does CJC-1295 + Ipamorelin cost?

CJC-1295 + Ipamorelin starts at $11.93 per vial (£9.42), sold in boxes of 10 at $119.28. One box is the smallest order and there is no trade account or minimum spend. Larger volumes are negotiable.

CJC-1295 + Ipamorelin price by strength. Billed in USD; GBP shown for reference. Each box contains 10 vials.
StrengthPer vialBox of 10
CJC-1295 5 mg + Ipamorelin 5 mg$11.93 £9.42$119.28 £94.23
Important: Both components are prohibited in competitive sport under WADA category S2, which covers peptide hormones, growth factors and related substances. Neither is approved for human use in any country. The 5 mg to 5 mg ratio is a convention of the research-chemical market rather than a researched proportion.

Handling

How should CJC-1295 + Ipamorelin be stored and reconstituted?

Sealed vials tolerate ambient temperature in transit and keep at −20 °C beyond that. Reconstitute slowly down the vial wall, swirl rather than shake, then refrigerate at 2–8 °C and aliquot before freezing.

Research Context

What is CJC-1295 + Ipamorelin researched for?

Below is a plain-English summary of what published research has investigated, and what it has found. These are descriptions of research activity and published results. They are not claims about what CJC-1295 + Ipamorelin does, and nothing here is a statement that it is safe or effective for any purpose.

Research status CJC-1295 and ipamorelin each have their own published literature, and unlike most blends in this market the principle behind pairing them has been tested: giving a GHRH analogue together with a growth-hormone-releasing peptide produces a larger growth hormone response in humans than either class produces alone. What has not been tested is this specific pairing at this specific ratio. Neither compound is approved for human use in any country, and both fall under WADA category S2.

What each component does

CJC-1295 without DAC is a 29-residue analogue of growth-hormone-releasing hormone, modified at four positions to resist enzymatic breakdown, acting at the GHRH receptor on pituitary somatotrophs. Ipamorelin is a five-residue selective agonist at the ghrelin receptor GHS-R1a, characterised in 1998 as the first secretagogue in its class to release growth hormone without a matching rise in cortisol, prolactin or ACTH. 12

Why the two are paired

The receptors are different and the pathways they drive converge on the same cell. Human work on GHRH given together with a growth-hormone-releasing peptide reports a response larger than the sum of the two given separately, and that synergy is the published basis for combining the classes rather than stacking two compounds from one class. 3

What is not established

The synergy studies used GHRH alongside GHRP-class peptides, not CJC-1295 alongside ipamorelin. No published study has tested this combination, and the 5 mg to 5 mg ratio is a market convention rather than a researched proportion. Whether the same synergy holds for these two particular molecules at this particular ratio is untested.

References

  1. 1Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab (2006). PMID 16352683
  2. 2Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol (1998). PMID 9849822
  3. 3Determinants of GH-releasing hormone and GH-releasing peptide synergy in men. Am J Physiol Endocrinol Metab (2009). PMID 19240251

Links open the record on PubMed or PubMed Central. These are citations to published research, not claims about this product.

Read this before citing any of the abovePreclinical means the work was done in cells or animals. Results in those systems very often fail to reproduce in humans. NobelPepLab supplies CJC-1295 + Ipamorelin for laboratory research only, does not provide dosing guidance, and does not supply products for human or veterinary use.

Applications

Where CJC-1295 + Ipamorelin is used in the laboratory

  • Somatotropic axis research where a releasing hormone and a secretagogue are applied to the same model rather than tested separately
  • Receptor crosstalk studies between the GHRH receptor and the ghrelin receptor GHS-R1a, two distinct receptors on the same pituitary cell type
  • Comparative work against single-agent CJC-1295 or ipamorelin, both of which we list separately
  • Method development where one co-lyophilised vial fixes the ratio across an entire batch and removes a reconstitution step from the workflow

Verification

Does CJC-1295 + Ipamorelin come with a COA?

Yes — every box. Each batch of CJC-1295 + Ipamorelin is analysed by Janoshik Analytical or Freedom Diagnostic, and the certificate is tied to the batch number on the vial label.

Example Certificate of Analysis issued by Janoshik Analytical

Example COA. You receive the certificate matching your own batch.

Questions

CJC-1295 + Ipamorelin questions, answered

Is the CJC-1295 in this blend the DAC or the non-DAC version?

Non-DAC, also sold as modified GRF 1-29. The distinction matters more than the name suggests. The DAC version carries a drug-affinity complex that binds albumin and stretches its plasma half-life to several days, while the non-DAC version clears in roughly half an hour. Blends of this kind are built with the non-DAC form so that both components act on a similar timescale - pairing a multi-day compound with a minutes-long one would not produce a combined pulse. The DAC version is listed separately on the CJC-1295 page.

How much does CJC-1295 + Ipamorelin cost?

CJC-1295 + Ipamorelin starts at $11.93 per vial, sold in boxes of 10 vials at $119.28 per box (about £94.23). 1 strength available: CJC-1295 5 mg + Ipamorelin 5 mg. There is no minimum order.

How is CJC-1295 + Ipamorelin shipped?

Tracked, in plain packaging, dispatched within 1–2 working days. Country-by-country estimates are on the shipping page.